{"id":2832,"date":"2025-02-06T14:22:23","date_gmt":"2025-02-06T11:22:23","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2832"},"modified":"2025-11-03T20:24:39","modified_gmt":"2025-11-03T17:24:39","slug":"percheron-therapeutics-announces-terminated-of-atl1102-study-for-dmd","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/es\/percheron-therapeutics-announces-terminated-of-atl1102-study-for-dmd\/","title":{"rendered":"Percheron Therapeutics anuncia la finalizaci\u00f3n del estudio ATL1102 para la DMD"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">\u201cOne way or other, we don\u2019t think ATL-1102 can remain the centerpiece of the story put forward to investors,\u201d Garner told investors in a webinar this morning.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In summary, the trial failed to detect any meaningful difference between the boys actively treated with ATL-1102, compared with the placebo cohort. [Read More: <a href=\"https:\/\/dmdwarrior.com\/percheron-disappointed-in-avicursen-atl1102-study-for-duchenne-dmd\/\">Percheron Disappointed in Avicursen (ATL1102) Study For Duchenne (DMD)<\/a>]<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<div class=\"youtube-embed\" data-video_id=\"mSEmhOawVlc\"><iframe title=\"Webinar Recording \u2013 Phase IIb results discussion.\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/mSEmhOawVlc?feature=oembed&#038;enablejsapi=1\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/div><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Read More<\/strong>:\u00a0<a href=\"https:\/\/dmdwarrior.com\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">Clinical Trials for Duchenne (List of All Researches)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cOne way or other, we don\u2019t think ATL-1102 can remain the centerpiece of the story put forward to investors,\u201d Garner told investors in a webinar this morning. In summary, the trial failed to detect any meaningful difference between the boys actively treated with ATL-1102, compared with the placebo cohort. [Read More: Percheron Disappointed in Avicursen [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2835,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[114,113,112,115],"class_list":["post-2832","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-atl1102","tag-avicursen","tag-percheron","tag-percheron-therapeutics"],"subtitle":"Percheron Therapeutics ha anunciado que abandonar\u00e1 por completo su principal f\u00e1rmaco candidato, tras el fracaso del ensayo sobre distrofia muscular de Duchenne de diciembre. Percheron Therapeutics anuncia la finalizaci\u00f3n del estudio ATL1102 para la DMD.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/2832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/comments?post=2832"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/2832\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media\/2835"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media?parent=2832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/categories?post=2832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/tags?post=2832"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}